Our results demonstrate that JWA deletion enhanced cellular DNA damage induced by DMBA at first stage, nevertheless attenuated tumor incidence induced by TPA at second stage and probably via inactivation of MAPK pathway. The gene discussed is ARL6IP5; the disease is neoplasm.